StockData
SANUWAVE Health, Inc. logo

SANUWAVE Health, Inc. (SNWV) stock

SNWVNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3026% below fair value
$1.82+0.24 (+15.19%)

Close on Nov 13, 2026Market cap $15.66MP/E –Yield –

SANUWAVE Health, Inc. grew revenue 0.8% to $41.33M over the twelve months to Sep 30, 2026. Operating income fell 109.5% to -$473.00K, moving the operating margin from 12.1% to -1.1%. Free cash flow was $2.60M. At the latest close the market valued the company at $15.66M.

Revenue
$41.33M
+0.8% vs. a year earlier
Operating income
-$473.00K
-109.5% vs. a year earlier
Free cash flow
$2.60M
TTM Q3 2026
EPS, diluted
$0.41
FY2025

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$15.66M
P/E ratio
–
Price to sales
0.38
Price to book
5.49
Dividend yield
–
Free cash flow yield
16.61%

Fundamentals

Revenue
$41.33M
Net income
$4.16M
EPS, diluted
$0.41
Free cash flow
$2.60M
Book value per share
$0.33
Diluted shares
9M

Trading

Next earnings
Mar 25, 2027 (estimated, after the close)
Previous close
$1.58
Open
$1.56
Day's range
$1.55 – $1.91
Volume
83,684
Average volume (20 days)
129,799
52-week range
$1.55 – $35.29
RSI (14 days)
25.9
Volatility (1 year)
108.9%
Relative volume
0.64×

Market cap history

Month-end market cap since 2011, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodSNWVS&P 500DifferenceSNWV per yearS&P 500 per year
1 month-67.6%-3.0%−64.5 pts
3 months-61.8%-2.8%−59.1 pts
Year to date-93.9%+11.5%−105.4 pts
1 year-94.6%+13.5%−108.0 pts
3 years+18100.0%+77.7%+18022.3 pts+466.7%+21.1%
5 years+1554.5%+72.6%+1481.9 pts+75.3%+11.5%
10 years+911.1%+308.2%+603.0 pts+26.0%+15.1%

Fifteen years at a glance

Fiscal years 2011 to 2025 and trailing twelve months, USD

Revenue

$41.33M+0.8% YoY

Gross profit

$31.49M-1.6% YoY

Operating income

-$473.00K-109.5% YoY

Net income

$4.16M

EPS, diluted

–

Free cash flow

$2.60M
Reported periodTrailing twelve months

Press releases

Releases SANUWAVE Health filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About SANUWAVE Health

Surgical & Medical Instruments & Apparatus

Sanuwave is a medical device enterprise specializing in directed energy solutions for regenerative medicine and wound care. The company focuses on noninvasive ultrasound technology designed to stimulate biological repair and tissue regeneration across musculoskeletal and vascular structures. Its primary commercial offering is the UltraMIST system, an FDA-cleared and patented platform that administers low-frequency, non-thermal ultrasound via a fluid mist without direct physical contact. The device treats acute and chronic wounds, including diabetic foot ulcers, surgical wounds, and deep tissue pressure injuries. Sanuwave supplies healthcare facilities, including hospitals, wound clinics, physician practices, nursing homes, and mobile wound care professionals.

Company profile, executives and history

SANUWAVE Health stock: common questions

What is SANUWAVE Health's stock price?

SNWV closed at $1.82 on Nov 13, 2026, up 15.19% on the day. Over the past 52 weeks it traded between $1.55 and $35.29.

What is SANUWAVE Health's market cap?

SANUWAVE Health was worth $15.66M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.

How much revenue does SANUWAVE Health make?

SANUWAVE Health reported revenue of $41.33M for the twelve months to Sep 30, 2026, up 0.8% from a year earlier.

Does SANUWAVE Health pay a dividend?

No. SANUWAVE Health has not paid a cash dividend over the last twelve months.

When does SANUWAVE Health report earnings next?

SANUWAVE Health is expected to report Q4 FY2026 results on Mar 25, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.

How has SNWV stock performed over the past year?

Including dividends, SNWV returned -94.6% over the past year, against +13.5% for the S&P 500.

Who are SANUWAVE Health's competitors?

Companies most similar to SANUWAVE Health by business, industry and size include RCEL, UTMD, PLSM, SNOA, BDMD.

See a number that looks wrong?